Neoadjuvant bleomycin, etoposide, and cisplatin (BEP) chemotherapy in the treatment of extensively advanced yolk sac tumors: A single center experience
International Journal of Gynecological Cancer | Apr 30, 2018
Racial differences in survival from epithelial ovarian cancer are associated with stage at diagnosis and use of neoadjuvant therapy: A 10-year single-institution experience with a racially diverse urban population
International Journal of Gynecological Cancer | Apr 30, 2018
Most read this week